US Broker Ratings

Metsera, Inc. (MTSR) Stock Analysis: Exploring a Promising 86% Upside in Biotechnology

Metsera, Inc. (MTSR), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to tackling obesity and related disorders. Headquartered in..

Amedisys Inc (AMED) Investor Outlook: Navigating Market Challenges in the Healthcare Sector

Amedisys Inc (AMED), a prominent player in the healthcare sector, continues to attract attention from investors seeking opportunities in the medical care facilities industry. With a..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 27% Potential Upside Amid Robust Revenue Growth

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) has been a standout performer in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $3.34..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Exploring a 15.86% Upside Potential in the Eye Health Market

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 32.62% Upside Potential in Rare Disease Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of biotechnology with a focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical entity, Rhythm’s market capitalization..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Strong Buy Ratings and 16.75% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector, has captured the attention of investors with its robust performance and promising growth..

RadNet, Inc. (RDNT) Stock Analysis: A 29% Upside Potential in the Healthcare Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With its expansive network of outpatient diagnostic imaging..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 41.73% Upside in the Biotech Space

Telix Pharmaceuticals Limited (TLX), an innovative player in the biotechnology sector, is making waves with its promising pipeline of radiopharmaceutical products aimed at treating cancer and..

Elanco Animal Health (ELAN): Investor Outlook with a 7.63% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) presents an intriguing opportunity for investors in the healthcare sector, specifically in the niche of animal health. As a company..

Guardant Health, Inc. (GH) Stock Analysis: Unlocking a 21% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH), a pioneering force in the healthcare sector, specifically within the Diagnostics & Research industry, is captivating investor interest with its formidable..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 40% Potential Upside in the Biotech Arena

Investors with a keen interest in the biotechnology sector are increasingly setting their sights on Soleno Therapeutics, Inc. (NASDAQ: SLNO), an intriguing player focused on rare..

Verona Pharma plc (VRNA) Stock Analysis: Is This $7.84 Billion Biotech a Breath of Fresh Air for Investors?

Verona Pharma plc (NASDAQ: VRNA), a biopharmaceutical company rooted in the United Kingdom, stands at the forefront of innovation within the respiratory disease sector. With a..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 38.53% Upside Potential for Investors

Bio-Rad Laboratories, Inc. (NYSE: BIO), a veteran in the healthcare sector, is a prominent player in the medical devices industry. Founded in 1952 and headquartered in..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Examining a 43% Upside Potential in Biotechnology

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), headquartered in West Conshohocken, Pennsylvania, is making waves in the biotechnology industry, a sector renowned for its high stakes and high..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 9.21% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, has become a focal point for investors seeking exposure to medical care facilities...

Corcept Therapeutics (CORT) Investor Outlook: Nearly 100% Upside Potential Awaits

Corcept Therapeutics Incorporated (NASDAQ: CORT), a dynamic player in the biotechnology sector, is capturing investor attention with its robust pipeline and impressive potential upside. With a..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 22% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, is making waves with its extensive range of home and alternate site infusion..

Integer Holdings Corporation (ITGR) Stock Analysis: Unlocking a 25.74% Upside Potential in Healthcare

Integer Holdings Corporation (NYSE: ITGR) has carved out a prominent position in the healthcare sector as a leading medical device contract development and manufacturing company. With..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 27.81% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a significant player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization..

Prestige Consumer Healthcare (PBH) Investor Outlook: Navigating a Stable Growth Path with a 5.39% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is carving a niche in the competitive healthcare market with its expansive portfolio of over-the-counter (OTC) health and personal care..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds